Paternal bone marrow infusion as salvage therapy for severe GVHD following maternal haploidentical transplantation resulting in biparental chimerism
- 6 September 2013
- journal article
- case report
- Published by Springer Science and Business Media LLC in International Journal of Hematology
- Vol. 98 (4), 504-508
- https://doi.org/10.1007/s12185-013-1426-5
Abstract
We describe a case of severe GVHD in a 3-year-old child who had received a maternal haploidentical allograft for thalassemia major, which was refractory to several lines of therapy, including weekly infusion of mesenchymal cells. The child was infused paternal marrow graft from which T cells were depleted using Campath ‘in the bag’ without conditioning. There was significant improvement in gut and liver GVHD over the next few weeks along with persistent mixed biparental chimerism before the child succumbed to CMV pneumonitis. This approach hints at the possibility of using parental TCD marrow to salvage GVHD caused by a graft from the other parent, and raises the possibility of biparental grafting along the same lines as double cord transplantation.Keywords
This publication has 11 references indexed in Scilit:
- Double Haploidentical Hematopoietic Stem Cell Transplantation Results in Successful Engraftment of Bone Marrow from Both Donors without Graft-versus-Host or Graft-versus-Graft EffectsTransplantation and Cellular Therapy, 2012
- Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantationExperimental Hematology, 2011
- Treatment of graft-versus-host-disease with mesenchymal stromal cellsCytotherapy, 2011
- Second allo-SCT from a different donor can improve severe steroid-resistant gut GVHDBone Marrow Transplantation, 2010
- Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 unitsBlood, 2009
- Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donorExperimental Hematology, 2008
- Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulinBlood, 2006
- Autologous/syngeneic stem cell transplantation to treat refractory GvHDBone Marrow Transplantation, 2004
- T‐cell depletion with Campath‐1H ‘in the bag’ for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft‐versus‐host disease, rapid immune constitution and improved survivalBritish Journal of Haematology, 2003
- Tolerance to histocompatibility determinants in tetraparental bone marrow chimeras.The Journal of Experimental Medicine, 1975